From: Visual and digital assessment of Ki-67 in breast cancer tissue - a comparison of methods
 | VA100 | VA500 | ||||
Low | Intermediate | High | Low | Intermediate | High | |
Cum. inc. 5 years, % (95% CI) | 18.8 (10.2–32.9) | 19.5 (13.5–27.7) | 32.5 (23.3–44.2) | 18.2 (9.5–33.1) | 17.4 (11.9–25.1) | 37.5 (27.5–49.7) |
Cum. inc. 10 years, % (95% CI) | 22.9 (13.4–37.6) | 28.5 (21.3–37.3) | 46.8 (36.4–58.5) | 25.0 (14.7–40.6) | 27.3 (20.5–35.7) | 48.6 (37.8–60.7) |
HR (95% CI) 1 | 1.00 | 1.01 (0.59–1.72) | 1.73 (1.01–2.98) | 1.00 | 1.01 (0.58–1.76) | 1.94 (1.1–3.42) |
Harrell’s C 1 |  | 0.58 |  |  | 0.59 |  |
 h (95% CI) 2 | 1.00 | 0.92 (0.53–1.60) | 1.4 (0.76–2.58) | 1.00 | 0.96 (0.55–1.68) | 1.65 (0.85–3.19) |
Harrell’s C 2 | 0.60 | 0.60 | ||||
 | DIA100 | DIA500 | ||||
 | Low | Intermediate | High | Low | Intermediate | High |
Cum. inc. 5 years, % (95% CI) | 15.9 (7.9–30.5) | 19.2 (12.9–28.2) | 31.0 (22.9–41.1) | 21.3 (13.7–32.4) | 17.0 (10.8–26.3) | 32.9 (23.7–44.4) |
Cum. inc. 10 years, % (95% CI) | 22.7 (12.9–38.1) | 26.9 (19.5–36.6) | 44.0 (34.9–54.3) | 28.0 (19.3–39.6) | 27.7 (19.8–37.9) | 44.3 (34.2–55.9) |
HR (95% CI) 1 | 1.00 | 1.14 (0.63–2.06) | 1.80 (1.02–3.19) | 1.00 | 1.00 (0.62–1.64) | 1.60 (0.99–2.58) |
Harrell’s C 1 |  | 0.58 |  |  | 0.57 |  |
 h (95% CI) 2 | 1.00 | 1.08 (0.59–1.97) | 1.48 (0.78–2.82) | 1.00 | 0.93 (0.56–1.53) | 1.27 (0.72–2.22) |
Harrell’s C 2 | 0.61 | 0.60 |